Details for New Drug Application (NDA): 208278

NDA 208278 describes AMANTADINE HYDROCHLORIDE, which is a drug marketed by Zydus, Actavis Elizabeth, Alembic, Bionpharma, Chartwell Molecular, Heritage Pharma, Humanwell Puracap, Invagen Pharms, Onesource Specialty, Rising, Rubicon Research, Sandoz, Strides Pharma, Upsher Smith Labs, Watson Labs, Watson Labs Inc, Zydus Pharms, Adaptis, Aurobindo Pharma Usa, Chartwell Rx, G And W Labs Inc, Ph Health, Pharm Assoc, Pharmobedient, Pom Pharma, Teva Pharms, Jubilant Generics, and Zhejiang Jutai Pharm, and is included in thirty-six NDAs. It is available from thirty-five suppliers. Additional details are available on the AMANTADINE HYDROCHLORIDE profile page.

The generic ingredient in AMANTADINE HYDROCHLORIDE is amantadine hydrochloride. There are seven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.

Summary for 208278

Tradename:	AMANTADINE HYDROCHLORIDE
Applicant:	Zydus Pharms
Ingredient:	amantadine hydrochloride
Patents:	0

Pharmacology for NDA: 208278

Mechanism of Action

M2 Protein Inhibitors

Medical Subject Heading (MeSH) Categories for 208278

Analgesics, Non-Narcotic

Antiparkinson Agents

Antiviral Agents

Dopamine Agents

Suppliers and Packaging for NDA: 208278

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
AMANTADINE HYDROCHLORIDE	amantadine hydrochloride	CAPSULE;ORAL	208278	ANDA	Zydus Lifesciences Limited	65841-835	65841-835-01	100 CAPSULE in 1 BOTTLE (65841-835-01)
AMANTADINE HYDROCHLORIDE	amantadine hydrochloride	CAPSULE;ORAL	208278	ANDA	Zydus Lifesciences Limited	65841-835	65841-835-05	500 CAPSULE in 1 BOTTLE (65841-835-05)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	100MG
Approval Date:	May 31, 2016	TE:	AB	RLD:	No

Complete Access Available with Subscription